 |
 |
| |
|
|
| |
The healthcare sector in undergoing a transformative shift, with the adoption of evidence-based treatments that are designed to prevent, manage and treat diseases. These treatments are enhancing patient care, harnessing digital methods to boost outcomes and drive significant growth. Healthcare companies that are prioritising these advancements are expected to make substantial impact.
A notable example of this is the evolution of precision oncology, which leverages genetic information to tailor cancer treatments. These advancements, along with others like Humira - biologic used to treat autoimmune conditions, mark the evolution and importance of innovative treatments.
Having said that, companies must also effectively manage market fluctuations caused by changing regulations, shifting patient demands and economic uncertainties. By diversifying their product portfolios, investing in research and development, and establishing strong partnerships, companies can navigate market challenges and thrive in a competitive landscape.
We at Acuity Knowledge Partners offer insights and intelligence programs that can be leveraged by healthcare leaders to assess opportunities in digital therapeutics and other disruptive technologies.
Manish Chandna – Director and Global Head, Consulting and Corporates
|
|
| |
|
|
|
Fresh and unique: Hand-picked content carefully curated for you
|
|
| |
|
|
|
|
HUMIRA’s 20-year reign
|
|
Precision oncology and its impact on cancer treatment
|
 |
|
 |
|
|
|
The insight paper throws light on Humira’s dominance in the immunology market. AbbVie, the maker of Humira, earned nearly $200 billion in revenue from the drug during its two decades of market exclusivity. However, biosimilars are slowly entering the market, raising challenges about Humira’s reign in immunology market.
|
|
The blog focuses on impact of precision oncology on cancer treatment. Precision oncology can reduce R&D costs and increase the ROI of oncology drugs, using companion diagnostics to select the most suitable patients for clinical trials and therapies.
|
|
|
|
|
|
| |
|
|
|
|
The evolution and impact of pharmaceutical market research
|
|
Advancements in cardiac devices and their impact on cardiovascular diseases
|
 |
|
 |
|
|
|
The insight paper focuses on the changing landscape of pharmaceutical market research, the integration of artificial intelligence, modern research methodologies, real-world applications, and the future of this dynamic field
|
|
The blog focuses on current advancements in cardiac devices and their impact on the diagnosis and treatment of cardiovascular diseases.
|
|
|
|
|
|
|
| |
|
|
|
Services offered by Acuity
|
|
| |
|
|
|
|
Healthcare market intelligence |
|
Pharma market intelligence
|
 |
|
 |
|
|
|
Acuity’s healthcare market intelligence programs enable healthcare innovators to do so with actionable technical and commercial insights based on scientific proof and opinions of key leaders.
|
|
Acuity’s team of subject-matter experts and significant expertise in strategic research and analysis, along with deep sector knowledge, have helped global pharma consulting and corporate clients implement tactical projects.
|
|
|
|
|
|
| |
|
|
| |
How Acuity Knowledge Partners can help
|
|
| |
|
|
| |
Acuity Knowledge Partners (Acuity) is a leading provider of high-value research, analytics and business intelligence services to life sciences, biopharma, MedTech and healthcare consulting firms. We provide bespoke research support on market entry and due diligence, portfolio management, , licensing and acquisition, go-to-market strategy, opportunity assessment, regulatory landscaping, product launch analysis, market access and therapy area assessment, indication prioritization, market research and forecasting, pipeline analysis and benchmarking and competitive intelligence.
|
|
| | | |
| |
| | |
| | |
ABOUT ACUITY KNOWLEDGE PARTNERS
Acuity Knowledge Partners (Acuity) is a leading provider of bespoke research, analytics and technology solutions to the financial services sector, including asset managers, corporate and investment banks, private equity and venture capital firms, hedge funds and consulting firms. Its global network of over 6,000 analysts and industry experts, combined with proprietary technology, supports more than 500 financial institutions and consulting companies to operate more efficiently and unlock their human capital, driving revenue higher and transforming operations. Acuity is headquartered in London and operates from 10 locations worldwide.
Acuity was established as a separate business from Moody’s Corporation in 2019, following its acquisition by Equistone Partners Europe (Equistone). In January 2023, funds advised by global private equity firm Permira acquired a majority stake in the business from Equistone, which remains invested as a minority shareholder.
For more information, visit www.acuitykp.com
|
|
| | | | | | US: +1 929 618 0217 | UK: +44 20 7550 4499 | India: +91 80 6113 3000
Sri Lanka: +94 11 235 6000 | Beijing: +86 10 8248 6812 | HK: +852 (972) 836-39 | contact@acuitykp.com | |
| | | |
| | | | | | ©2024 Acuity Knowledge Partners. All rights reserved. | |
| | | |
| |